ASNC recently joined a coalition of 6 medical societies asking the Department of Commerce and the Trump Administration to exclude or defer tariffs on radiopharmaceuticals and medical isotopes until adequate domestic supplies are established.
In their letter to U.S. Secretary of Commerce Howard Lutnick, ASNC and the American Association of Physicists in Medicine, American College of Cardiology (ACC), American College of Radiology, American Society for Radiation Oncology, and Society of Nuclear Medicine and Molecular Imaging, urged the Administration to continue collaborating with stakeholders on efforts to strengthen domestic production capacity and to develop a national strategy for radiopharmaceutical supply chain security that includes contingency planning for future disruptions.
The coalition reiterated comments submitted by ASNC and the ACC in May, shortly after the Commerce Department requested input on its section 232 investigation aimed at determining the effects on national security of importing pharmaceuticals and pharmaceutical ingredients.
Related Posts
ASNC Industry Forum Brings Leaders Together to Brainstorm Advancing Nuclear Cardiology
Strengthening nuclear cardiology’s position in the increasingly competitive cardiovascular imaging landscape was…
ASNC’s First AI Summit Explores Opportunities to Advance Nuclear Cardiology
“The ASNC AI Summit brought together a tremendous range of expertise and…
Policymakers Detail Legislative Priorities Ahead of Midterm Elections
Regardless of which party controls Congress after the Nov. 3 midterm elections,…


